Behind the deal: how IPValue snagged 5,000 Intel patents
The executive vice president of partnerships and acquisitions at the NPE explains how his company’s deal with Intel came to be
South Korean lawyers welcome the trademark guidelines but say the appellate board, courts, and other IP offices may not necessarily agree with the KIPO
Lawyers for Craig Wright will seek approval for expert evidence to help the England and Wales High Court understand how autism affects his character
Ken Korea, founder of Colev Law and former head of US IP at Samsung, sets out the problems with anti-suit injunctions and the problem of getting rid of them
Lawyers at new Russian firms say parting ways with old colleagues has been hard, but that they are looking to seize new opportunities
Counsel at three NPEs, two tech companies, a law firm and a litigation funder reveal what the random distribution of patent cases in Waco means for their strategies
Organisation and investment in technology could stop disclosure failings, say lawyers, after thousands of missing documents create a two-year delay to trial
USPTO announces new inclusion initiatives; CBA sues Bilibili for $60m; Japan and Germany dominate future innovators list; Sony flags own website; Interpol nets $11m of fake drugs; Apple avoids earphone infringement trial
VR brand ‘crushed’ by ‘toxic’ Meta; UPC reveals amended opt-out system; UK ambassador supports Ukraine; Grand Board of Appeal sets date for first oral hearing; Manolo Blahnik wins 20-year China TM case; USPTO seeks public comment on PTAB processes
Shaw, who worked at the ITC for more than a decade, has replaced Suzanne Barnett as chief judge of the Copyright Royalty Board
Thales can’t block Philips from ITC; Canon IP chief elected IP Federation president; Pfizer and Moderna vaccines ‘violate new patent’; UKIPO plots further designs review; USPTO requests official PTA form
Thom Tillis and Patrick Leahy introduced a bill that would evaluate the need for recording examiner interviews, among other measures
The head of the OEPM says IP offices should lead the public conversation on innovation
The EPO is planning an overhaul of its examination system, and counsel say it’s a chance to fix some long-lasting issues
The patent office is seeking comments on its subject matter eligibility guidance
Charles Feng, partner at East & Concord in Beijing, explains why filing for a trademark early is still a brand’s best bet
Sources say Manolo Blahnik’s trademark victory in China last month shows brands can win out against bad-faith filers
Counsel who have advised smaller business in trademark litigation say funders are becoming more important and that jury sympathy is nice but won’t win cases
The long-running dispute that centres on broad trademark filings and what constitutes bad faith will be heard by highest court in the land
Jurisdictions
Exclusives and This week in IP
Exclusives and This week in IP
-
Sources close to the court, as well as one hopeful applicant, told Managing IP that official offers have yet to be sent
-
The UPC held a pilot training system for its new IT system in London last Thursday, June 30, and a full programme will follow later this year
CAS
Sponsored by
CAS
CAS explains the five high-risk areas of IP for R&D organisations and identifies how companies can protect their innovations and safeguard their growth potential
Sponsored by
CAS
CAS shares how patent offices around the world are adopting AI, and explains the benefits of clean data, multiple algorithms, and leveraging human expertise alongside technology
Sponsored by
CAS
The CAS IP Research Team analyse how organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation
Sponsored by
CAS
Peter Blasi, business development manager at CAS IP Search, explains how to set standards for an effective IP search
Features and Special Focus
Features and Special Focus
Sponsored
Sponsored
-
Sponsored by Wanhuida Intellectual PropertyYue Guan of Wanhuida Intellectual Property analyses a decision by the China National Intellectual Property Administration on the validity of a pulmonary hypertension drug and the implications for pharmaceutical patentees
-
Sponsored by Purplevine IPXiaoyan Zhou of Purplevine IP explains how the introduction of administrative measures for registering, and filing records relating to, medical devices in China should affect companies’ IP strategy
-
Sponsored by CASAnne Marie Clark, senior patent searcher at CAS, looks at ways to protect and commercialise the promise of RNAi